A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Celldex Therapeutics
Celldex Therapeutics
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Fudan University
Yale University
Boston Scientific Corporation
Light Sciences LLC
Light Sciences LLC
FeRx